Key statistics
As of last trade Telesis Bio Inc (TBIO:PKC) traded at 0.97, 9.12% above its 52-week low of 0.8889, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.02 |
---|---|
High | 1.02 |
Low | 0.95 |
Bid | -- |
Offer | -- |
Previous close | 0.91 |
Average volume | 12.38k |
---|---|
Shares outstanding | 1.78m |
Free float | 1.23m |
P/E (TTM) | -- |
Market cap | 1.62m USD |
EPS (TTM) | -29.66 USD |
Data delayed at least 15 minutes, as of Nov 13 2024 20:26 GMT.
More ▼
- Telesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
- Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
- Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
- Telesis Bio Reports First Quarter 2024 Financial Results
- Telesis Bio Announces Reverse Stock Split
- Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership
- Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
- Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results
- Telesis Bio Reports Third Quarter 2023 Financial Results
More ▼